[go: up one dir, main page]

HK1227849A1 - Heterocyclic compounds and uses thereof - Google Patents

Heterocyclic compounds and uses thereof Download PDF

Info

Publication number
HK1227849A1
HK1227849A1 HK17101255.9A HK17101255A HK1227849A1 HK 1227849 A1 HK1227849 A1 HK 1227849A1 HK 17101255 A HK17101255 A HK 17101255A HK 1227849 A1 HK1227849 A1 HK 1227849A1
Authority
HK
Hong Kong
Prior art keywords
heterocyclic compounds
kinase activity
compounds
pharmaceutical compositions
diseases
Prior art date
Application number
HK17101255.9A
Other languages
Chinese (zh)
Other versions
HK1227849B (en
Inventor
阿尔弗雷多．C．卡斯特罗
凯瑟琳．A．埃文斯
S．加纳达南奈尔
A.莱斯卡博
刘涛
马丁．R．特伦布莱
Original Assignee
无限药品股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 无限药品股份有限公司 filed Critical 无限药品股份有限公司
Publication of HK1227849A1 publication Critical patent/HK1227849A1/en
Publication of HK1227849B publication Critical patent/HK1227849B/en

Links

Abstract

Compounds and pharmaceutical compositions that modulate kinase activity, including PI3 kinase activity, and compounds, pharmaceutical compositions, and methods of treatment of diseases and conditions associated with kinase activity, including PI3 kinase activity, are described herein.
HK17101255.9A 2013-10-04 2014-10-03 Heterocyclic compounds and uses thereof HK1227849B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61/887,259 2013-10-04
US61/888,958 2013-10-09
US61/938,026 2014-02-10

Publications (2)

Publication Number Publication Date
HK1227849A1 true HK1227849A1 (en) 2017-10-27
HK1227849B HK1227849B (en) 2022-04-08

Family

ID=

Similar Documents

Publication Publication Date Title
HK1207069A1 (en) Heterocyclic compounds and uses thereof
PH12016500582A1 (en) Heterocyclic compounds and uses thereof
HK1199725A1 (en) Heterocyclic compounds and uses thereof
HK1198443A1 (en) Heterocyclic compounds and uses thereof
WO2012064973A3 (en) Heterocyclic compounds and uses thereof
PH12016501809A1 (en) Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders
WO2012116237A3 (en) Heterocyclic compounds and uses thereof
HK1216175A1 (en) Therapeutic compounds and compositions
WO2015077503A8 (en) Autotaxin inhibitor compounds
IL255509B (en) Compounds as ccr2 modulators, pharmaceutical compositions comprising same and their use for the treatment of diseases
WO2014205389A8 (en) Nuclear transport modulators and uses thereof
WO2016004305A3 (en) Inhibitors of bruton's tyrosine kinase
EP2967049A4 (en) Methods, compounds, and compositions for the treatment of angiotensin-related diseases
WO2015066302A3 (en) Compositions, methods of use, and methods of treatment
EP3034082A4 (en) Pharmaceutical composition for treating or preventing neuropsychitric disease, containing flavone-6-c-glucose derivatives as active ingredients
EP3176163A4 (en) Novel indene derivative, preparation method for same, and pharmaceutical composition, for preventing or treating retinal diseases, containing same as active ingredient
EA032271B9 (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
EP3103453A4 (en) Medicinal composition comprising diamino heterocyclic carboxamide compound as active ingredient
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
MX382092B (en) Heterocyclic compounds for the treatment of disease
CL2015003431A1 (en) Pyridone derivatives for the treatment of viral infections and additional diseases
EP2994156A4 (en) Compounds, compositions and methods for the treatment of diseases through inhibiting tgf- activity
EP3260121A4 (en) Composition for preventing, alleviating or treating metabolic diseases, containing amodiaquine as active ingredient
EP3235808A4 (en) Modified taurine, and pharmaceutical composition for preventing or treating metabolic diseases containing same
WO2016144704A3 (en) Heterocyclic autotaxin inhibitor compounds